An integrated cognitive assessment known as CognICA is a five-minute cognitive test that uses an application deliverable to an iPad. CognICA was developed by Cognetivity Neurosciences and in 2021 was given FDA approval for its commercial use as a medical device. CognICA had earlier been approved for use in the UK.
CognICA is highly sensitive to the early stages of dementia.